AnandRathi

Alivus Life Sciences Ltd Fundamental Analysis

Last Updated Date: 21 Oct 2026
₹1,245.70
-27.20 (-2.14%)

Alivus Life Sciences Ltd (Alivus Life) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹15,628 crore.

Alivus Life Sciences Ltd Overview

Market cap₹15,628 Crs
Volume2,935
Prev. Close₹1,272.90
Year range₹830.00 - ₹1,495.30
ISININE03Q201024

Alivus Life Sciences Ltd Fundamentals

ROCE(TTM)22.33%
P/E Ratio (TTM)25.91
P/B Ratio4.69
Debt to Equity0.02
ROE16.94%
EPS (TTM)50.64
Dividend Yield0.39%
Book Value271.41
Profit Margin24.00%
Operating Margin29.25%

Alivus Life Sciences Ltd Historical Performance

1 Month Return-11.05%
6 Month Return19.80%
3 Year Return104.19%
3 Month Return12.28%
1 Year Return38.40%
5 Year Return105.87%

Alivus Life Sciences Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research